ARK Investment Management LLC
Q3 2022 13F-HR Holdings
Net value change ($000)
-2,562,511
(-15.2%)
New positions
9
Sold out positions
113
Turnover %
1.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| DNA | 126,612 | 47.1% |
| NTLA | 101,406 | 23.1% |
| BEAM | 95,203 | 30.8% |
| Verve Therapeutics, Inc. | 85,742 | 278.0% |
| RBLX | 82,024 | 37.0% |
| NVDA | 41,636 | 33.0% |
| SomaLogic, Inc. | 31,951 | NEW |
| DKNG | 31,583 | 9.2% |
| BFLY | 29,315 | 135.5% |
| GH | 29,182 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,738
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|